GAD2 and major depressive disorder: SARS-COV-2 has brought fear, anxiety an depression to many affected and non affected COVID-19 individuals (Kupcova et al., 2023), and these psycho-emotion state in combination with viral challenges could be responsible for an increases of antoantibodies GAD65 in persons already suffering from diabetes type 1.